Back to Agenda
[V5-S3] How to Provide Drug Information from a Standpoint of a Patient (Part 2)
Session Chair(s)
Yuko Kojima, RPH
Sr. Executive Director, Eli Lilly Japan K.K., Japan
Mamoru Narukawa, PHD, RPH
Professor, Kitasato University, Japan
Determining what information patients and medical experts need, and how to make the information available to ensure proper drug use, is an essential issue. We will discuss various medical communication tools created by the pharmaceutical industry to encourage appropriate drug use (i.e., for medical experts, package inserts, interview forms, and guides for appropriate use; for patients, drug guides, and drug information sheets).
Speaker(s)
Tomoko Tanita
Risk Communication Promotion Division, Office of Safety I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Junichi Nishino, MSC, RPH
Head, Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd., Japan
Masahiro Hayashi, PHD
Pharmaceutical affairs specialist, Department of Pharmacy, Toranomon Hospital, Japan
Have an account?